论文部分内容阅读
近些年来,医药商业贿赂事件在我国频频发生,特别是一些大型跨国医药企业的商业贿赂事件,在社会上产生了巨大的负面影响,影响了我国医药行业的市场发展。这种不正当竞争行为严重破坏了我国的经济秩序并损害了国家和人民的切身利益。本文通过介绍医药商业贿赂的含义及表现形式,分析了我国法律及政策治理的现状及存在的问题,最后从法律、政府、医疗机构三个方面提出治理医药商业贿赂的可行性建议,以期对现存的医药商业贿赂的法律及政策治理有所帮助。
In recent years, the commercial bribery incident in our country has been frequent in our country. In particular, the commercial bribery incident in some large multinational pharmaceutical enterprises has had a huge negative impact on the society and has affected the market development of the pharmaceutical industry in our country. Such acts of unfair competition seriously undermine our economic order and undermine the vital interests of our country and our people. This article introduces the meaning and manifestation of the commercial bribery in the pharmaceutical industry, analyzes the status quo and existing problems of the legal and policy governance in our country, and finally puts forward the feasible suggestion to cure the commercial commercial bribe from three aspects of law, government and medical institution, The medical and commercial bribery laws and policy governance help.